berberine has been researched along with Adenoma in 5 studies
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Individuals aged 18-75 years who had at least one but no more than six histologically confirmed colorectal adenomas that had undergone complete polypectomy within the 6 months before recruitment were recruited and randomly assigned (1:1) to receive berberine (0·3 g twice daily) or placebo tablets via block randomisation (block size of six)." | 9.34 | Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. ( Cao, HL; Cao, XC; Chen, HM; Chen, YX; Dou, XT; Fang, JY; Gao, QY; Kang, Q; Li, N; Liu, SD; Liu, ZJ; Ren, JL; Sheng, JQ; Song, YY; Sun, XM; Wang, BM; Xiao, B; Xu, HZ; Yang, XN; Zhu, W; Zou, TH; Zou, XP, 2020) |
| "Berberine(BBR) is a kind of isoquinoline alkaloids extracted from the rhizomes of Coptis chinensis Franch." | 6.82 | Efficacy and safety of berberine in preventing recurrence of colorectal adenomas: A systematic review and meta-analysis. ( Cao, Z; Du, S; Fang, S; Guo, S; Su, X; Wei, W; Yang, Y, 2022) |
| " Individuals aged 18-75 years who had at least one but no more than six histologically confirmed colorectal adenomas that had undergone complete polypectomy within the 6 months before recruitment were recruited and randomly assigned (1:1) to receive berberine (0·3 g twice daily) or placebo tablets via block randomisation (block size of six)." | 5.34 | Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. ( Cao, HL; Cao, XC; Chen, HM; Chen, YX; Dou, XT; Fang, JY; Gao, QY; Kang, Q; Li, N; Liu, SD; Liu, ZJ; Ren, JL; Sheng, JQ; Song, YY; Sun, XM; Wang, BM; Xiao, B; Xu, HZ; Yang, XN; Zhu, W; Zou, TH; Zou, XP, 2020) |
| "Berberine(BBR) is a kind of isoquinoline alkaloids extracted from the rhizomes of Coptis chinensis Franch." | 2.82 | Efficacy and safety of berberine in preventing recurrence of colorectal adenomas: A systematic review and meta-analysis. ( Cao, Z; Du, S; Fang, S; Guo, S; Su, X; Wei, W; Yang, Y, 2022) |
| "Accumulating evidence links colorectal cancer (CRC) with the intestinal microbiota." | 1.42 | Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. ( An, HF; Chen, HM; Chen, HY; Fang, JY; Hong, J; Li, M; Ma, X; Qin, WX; Shen, N; Sun, TT; Weng, YR; Yu, J; Yu, TC; Yu, YN; Zhao, HJ, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, S | 1 |
| Guo, S | 1 |
| Du, S | 1 |
| Cao, Z | 1 |
| Yang, Y | 2 |
| Su, X | 1 |
| Wei, W | 1 |
| Tan, S | 1 |
| Ou, Y | 1 |
| Huang, S | 1 |
| Chen, S | 1 |
| Gao, Q | 1 |
| Chen, YX | 1 |
| Gao, QY | 1 |
| Zou, TH | 1 |
| Wang, BM | 1 |
| Liu, SD | 1 |
| Sheng, JQ | 1 |
| Ren, JL | 1 |
| Zou, XP | 1 |
| Liu, ZJ | 1 |
| Song, YY | 1 |
| Xiao, B | 1 |
| Sun, XM | 1 |
| Dou, XT | 1 |
| Cao, HL | 1 |
| Yang, XN | 1 |
| Li, N | 1 |
| Kang, Q | 1 |
| Zhu, W | 1 |
| Xu, HZ | 1 |
| Chen, HM | 2 |
| Cao, XC | 1 |
| Fang, JY | 2 |
| Kwon, S | 1 |
| Chan, AT | 1 |
| Yu, YN | 1 |
| Yu, TC | 1 |
| Zhao, HJ | 1 |
| Sun, TT | 1 |
| Chen, HY | 1 |
| An, HF | 1 |
| Weng, YR | 1 |
| Yu, J | 1 |
| Li, M | 1 |
| Qin, WX | 1 |
| Ma, X | 1 |
| Shen, N | 1 |
| Hong, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-controlled, Multicenter, Prospective Clinical Study of Berberine Hydrochloride in Preventing Recurrence and Carcinogenesis After Endoscopic Removal of Colorectal Adenomas[NCT02226185] | Phase 2/Phase 3 | 1,108 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis: a Prospective Cohort Study[NCT04543643] | Phase 3 | 288 participants (Anticipated) | Interventional | 2021-11-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for berberine and Adenoma
| Article | Year |
|---|---|
Efficacy and safety of berberine in preventing recurrence of colorectal adenomas: A systematic review and meta-analysis.
Topics: Adenoma; Berberine; Colorectal Neoplasms; Coptis chinensis; Humans | 2022 |
Preventive effects of chemical drugs on recurrence of colorectal adenomas: systematic review and Bayesian network meta-analysis.
Topics: Adenoma; Berberine; Colorectal Neoplasms; Humans; Network Meta-Analysis; Randomized Controlled Trial | 2024 |
1 trial available for berberine and Adenoma
| Article | Year |
|---|---|
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprev | 2020 |
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprev | 2020 |
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprev | 2020 |
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprev | 2020 |
2 other studies available for berberine and Adenoma
| Article | Year |
|---|---|
Extracting the benefits of berberine for colorectal cancer.
Topics: Adenoma; Antineoplastic Agents, Phytogenic; Aspirin; Berberine; Cardiovascular Diseases; Case-Contro | 2020 |
Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Topics: Adenoma; Animals; Berberine; Blotting, Western; Cell Transformation, Neoplastic; Colorectal Neoplasm | 2015 |